Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD38 CAR-T for Relapsed B-ALL After CD19 CAR-T
NCT03754764Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Nov 2018
- Primary completion
- Nov 2022
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CAR-T-38 in B cell acute lymphoblastic leukemia (B-ALL), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
CAR-T-38
03
Conditions
B cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT03754764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03754764.